Association between noninvasive fibrosis markers and mortality among adults with nonalcoholic fatty liver disease in the United States

Cited by (772)

Items 601–700 of 772

1. Similarities and Differences Between Nonalcoholic Steatohepatitis and Other Causes of Cirrhosis
   Naga Swetha Samji, Rajiv Prakash Heda, Alexander J. Kovalic, Sanjaya Kumar Satapathy · 2019 · Gastroenterology Clinics of North America
2. Treatment with phosphatidylcholine of patients with nonalcoholic fatty liver disease: a prospective pilot study
   Ludovico Abenavoli, R. G. Myazin, Sharmila Fagoonee, Pietro Cinaglia, Francesco Luzza, Rinaldo Pellicano, Dmitry Emelyanov · 2022 · Minerva Gastroenterology
3. CAR Protects Females from Diet-Induced Steatosis and Associated Metabolic Disorders
   Fabiana Oliviero, Wendy Klément, Lucile Mary, Yannick Dauwe, Yannick Lippi, Claire Naylies, Véronique Gayrard, Nicola Marchi, Laïla Mselli-Lakhal · 2023 · Cells
4. Liver fibrosis in pars cohort study: A large-scale study on the prevalence and correlated factors
   Amin Nakhostin-Ansari, Seyed Hossein Hosseini-Asl, Fatemeh Aliasgharpour, Mohammad Ahmadi, Abdollah Gandomkar, Fatemeh Malekzadeh, Hossein Poustchi, Mohammad Reza Fattahi, Amir Anushiravani, Reza Malekzadeh · 2023 · Arab Journal of Gastroenterology
5. MODERN NON-INVASIVE METHODS OF DIAGNOSTICS OF LIVER FIBROSIS IN CHILDREN
   Ивлева Светлана Анатольевна, Igor V. Dvoryakovskiy, Ivan E. Smirnov · 2019 · Russian Pediatric Journal
6. NAFLD therapy and monitoring disease progression
   Pankaj Puri, Vijayalakshmi Aravindan Arun · 2017 · Tropical Gastroenterology
7. Development and validation of a simple risk model to predict major cancers for patients with nonalcoholic fatty liver disease
   Zihan Wei, Zhigang Ren, Shuang Hu, Yan Lin Gao, Ranran Sun, Shuai Lv, Guojie Yang, Zujiang Yu, Quancheng Kan · 2019 · Cancer Medicine
8. The Fibrosis-4 index predicts all-cause mortality in a cohort of patients at high cardiovascular risk partly through glomerular filtration rate reduction
   Antonio Mirijello, Gabriella Pacilli, Antonio Siena, Antonio Mangiacotti, Maria Maddalena D’Errico, Daria Dilalla, Olga Lamacchia, Andrea Fontana, Massimiliano Copetti, Pamela Angela Piscitelli et al. · 2024 · Nutrition Metabolism and Cardiovascular Diseases
9. Evolving burden of metabolic dysfunction–associated steatotic liver disease and its complications in a US nationwide healthcare system
   Basim Ali, Ronald E. Samuel, Jennifer R. Kramer, Liang Li, Xian Yu, Yumei Cao, Roxanne Desiderio, George T. Cholankeril, Steven M. Asch, Hashem B. El‐Serag et al. · 2026 · Hepatology Communications
10. Association between metabolic dysfunction-associated fatty liver disease and cardiovascular autonomic neuropathy in type 2 diabetes
    Rong Peng, Yaoyun Ao, Enni Cen, Junnian Chen, Zeshan Huang, FU Xiaoying, Jian Kuang, Shuiqing Lai, S. Zhang · 2026 · Frontiers in Endocrinology
11. The Association Between Fibrosis‐4 Index and All‐Cause and Cardiac Mortality in Patients With Coronary Heart Disease Combined With Diabetes or Prediabetes: Findings From Two Large‐Scale Prospective Cohort Studies
    Chenxi Song, Zhihao Zheng, Xiaohui Bian, Zheng Qiao, Jiaxi Cheng, Wanqing Sun, Chunyue Wang, Bowen Li, Pengyu Liu, Yuqin He et al. · 2026 · MedComm
12. Comparison of fatty liver index with fibroscan in non-alcoholic fatty liver disease
    Marium Ahmed, Rabeeya Saeed, Lubna Kamani, Noureen Durrani, Faraz Ahmed · 2024 · Journal of Family Medicine and Primary Care
13. Estimated pulse wave velocity in metabolic dysfunction‐associated steatotic liver disease and all‐cause/cause‐specific mortality
    Donghee Kim, Richie Manikat, Karn Wijarnpreecha, George T. Cholankeril, Aijaz Ahmed · 2024 · Journal of Gastroenterology and Hepatology
14. The cross–sectional association between ultra-processed food intake and metabolic dysfunction-associated steatotic liver disease
    Natalie Z. Sun, Brenton R. Prescott, Jiantao Ma, Vanessa Xanthakis, Paula A. Quatromoni, Michelle T. Long, Maura E. Walker · 2025 · Clinical Nutrition ESPEN
15. Metabolic dysfunction-associated fatty liver disease (MAFLD) in the adult population attending a health check-up program in Thailand: prevalence and fibrosis status
    Supinya Sono, Apichat Kaewdech, Chutimon Wongsawanon, Thatchaphon Varanuntakul, Tian Jarupanich, Nichakan Sritanabutr, Papontee Ruangtanthawat, Monchusa Phanukasemsin, Lipikar Inchan, Naichaya Chamroonkul et al. · 2025 · Scientific Reports
16. Concepts and Treatment Approaches in Nonalcoholic Fatty Liver Disease
    Dina Halegoua‐De Marzio, Jonathan M. Fenkel · 2014 · Advances in Hepatology
17. Liver Fibrosis Scoring Systems as Novel Tools for Predicting Recurrent Cardiovascular Events in Patients with a Prior Cardiovascular Event
    Huihui Liu, Ye‐Xuan Cao, Jing‐Lu Jin, Yuan‐Lin Guo, Cheng‐Gang Zhu, Na‐Qiong Wu, Qi Hua, Yanfang Li, Li-Feng Hong, Qian Dong et al. · 2021 · Cardiology Discovery
18. Hepatoprotective Effect of Morin Hydrate in Type 2 Diabetic Wistar Rats Exposed to Diesel Exhaust Particles
    Ibukun Mary Folorunso, Akeem O. Lawal, Olusola Olalekan Elekofehinti, Opeyemi Iwaloye · 2023 · Applied Biochemistry and Biotechnology
19. Positive hepatitis B core antibody is associated with advanced fibrosis and mortality in nonalcoholic fatty liver disease
    Pengyan Zhang, Zhenqiu Liu, Hong Xia Fan, Tingting Shi, Xinyu Han, Chen Suo, Xingdong Chen, Tiejun Zhang · 2022 · European Journal of Gastroenterology & Hepatology
20. Correlation between Coronary Artery Disease and Non-Alcoholic Fatty Liver Disease Using Computed Tomography Coronary Calcium Scans.
    Dragoș Constantin Cucoranu, Marian Pop, Raluca Niculescu, Irina-Bianca Kosovski, Radu Ovidiu Togănel, Răzvan-Andrei Licu, Anca Bacârea · 2023 · PubMed Central
21. Non-alcoholic fatty liver disease biomarkers estimate cardiovascular risk based on coronary artery calcium score in type 2 diabetes: a cross-sectional study with two independent cohorts
    Damien Denimal, Maharajah Ponnaiah, Anne-Caroline Jeannin, Franck Phan, Agnès Hartemann, Samia Boussouar, Etienne Charpentier, Alban B. Redheuil, Fabienne Foufelle, Olivier Bourron · 2024 · Cardiovascular Diabetology
22. Non-Invasive Serum Markers of Non-Alcoholic Fatty Liver Disease Fibrosis: Potential Tools for Detecting Patients with Cardiovascular Disease
    Ling-Zi Chen, Xubin Jing, Xiang Chen, Yanchun Xie, Yun Chen, Xianbin Cai · 2024 · Reviews in Cardiovascular Medicine
23. Interaction between the non-alcoholic fatty liver disease fibrosis score and vitamin D deficiency on left ventricular hypertrophy and impaired diastolic function in patients with type 2 diabetes mellitus
    Yunming Li, Jiayi Huang, Ran Guo, Shiming Li, Cong Chen, Min Wu, Run Wang, Ming-Ya Liu, Kai Hang Yiu · 2025 · Diabetology & Metabolic Syndrome
24. METABOLIC TANDEM TARGETS: NON-ALCOHOLIC FATTY LIVER DISEASE AND TYPE 2 DIABETES MELLITUS
    L. A. Zvenigorodskaya, Ashot Musaelovich Mkrtumyan, Шинкин Михаил Викторович, Т. В. Нилова, А. В. Петраков · 2017 · Meditsinskiy sovet = Medical Council
25. Intrahepatic Fat Content and Markers of Hepatic Fibrosis in Obese Children
    Wei Wu, Hongxi Zhang, Xiaoqin Xu, Ke Huang, Junfen Fu · 2016 · International Journal of Endocrinology
26. Nafld and cardiovascular risks: clinic, diagnostic, features of therapy
    R. G. Myazin · 2019 · Meditsinskiy sovet = Medical Council
27. Non-alcoholic fatty liver disease: the role of the nurse
    Lea Ladegaard Grønkjær, Charlotte Wilhelmina Wernberg, Mette Munk Lauridsen · 2020 · Gastrointestinal Nursing
28. An ALTer Ego of Serum ALT: Is It More Than a Marker of Liver Inflammation?
    Donghee Kim, W. Ray Kim · 2013 · Gastroenterology
29. Does Metabolic Syndrome and Not the Inflammatory Load Predict Nonalcoholic Fatty Liver Disease Severity in Inflammatory Bowel Disease Patients?
    Alessandro Sartini, Stefano Gitto, Erica Villa · 2017 · Digestive Diseases and Sciences
30. Exercise attenuates hepatic ectopic lipid deposition in high fat-diet rats via PKA-mediated phosphorylation of Perilipin5
    Shang-Yan Dong, Yang Yang, Wei Li, Lifeng Wang, Ting Li · 2025 · Scientific Reports
31. Prognostic value of non-invasive fibrosis assessment scores in predicting mortality among individuals with metabolic dysfunction-associated steatotic liver disease
    Lingjie Wu, Shunling Cai, Zhongbin Lin, Ruilie Chen, Yuanfeng Zhang, Xiaobing Gong · 2026 · BMC Public Health
32. Association and Diagnostic Performance of the Atherogenic Index of Plasma and Carotid Intima-Media Thickness in Non-alcoholic Fatty Liver Disease: A Cross-Sectional Study
    Bharath V Karnati, Pradip Kumar Behera, Krishna Padarabinda Tripathy, Rama Sowmya Karanam, Aparajita Priyadarshini, Swati Das, Subhashree Mishra · 2026 · Cureus
33. Effects of Dapagliflozin on Cardiovascular Outcomes in Patients With Type 2 Diabetes at Risk of Liver Fibrosis
    Jan Oscarsson, Monika Huhn, Yunyun Jiang, Ingrid A. M. Gause‐Nilsson, Stephen D. Wiviott, Filipe A. Moura, John P.H. Wilding, Simona Cernea, Van Gaal L, Avivit Cahn et al. · 2026 · Diabetes Obesity and Metabolism
34. Trends in the high blood glucose and non-alcoholic fatty liver disease among Korean adolescents
    Youn Huh, Ga Eun Nam, Jisun Lim, Hye Soon Park · 2022 · Endocrine Journal
35. Imaging Evaluation of the Living Liver Donor: A Systems-Based Approach
    Ryan E. Bailey, Rosa Alba Pugliesi, Daniel Borja–Cacho, Amir Ali Borhani · 2023 · Radiologic Clinics of North America
36. Liver Fibrosis as an Independent Cardiovascular Risk Factor in Non-alcoholic Fatty Liver Disease
    Dmitry Victorovich Garbuzenko · 2024 · Journal of Translational Gastroenterology
37. Biomarker for cardiorenal syndrome risk in patients with liver cirrhosis and type 2 diabetes in Saudi Arabia
    Walaa M. Mohammedsaeed, Zain Alghamdi · 2024 · Saudi Medical Journal
38. Fibrosis-4 Score Is Associated with Mortality in Hemodialysis Patients with Chronic Viral Hepatitis: A Retrospective Study
    Hao-Hsuan Liu, Chieh‐Li Yen, Wen‐Juei Jeng, Cheng‐Chieh Hung, Ching-Chung Hsiao, Ya-Chung Tian, Kuan‐Hsing Chen · 2024 · Diagnostics
39. Cultural and Molecular Factors Predisposed to Non-Alcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus
    H. George, Fajar Shodiq Permata, Crystal M. D’Souza, Ernest A Adeghate · 2025 · Nutrients
40. Biochemical Biomarkers of NAFLD/NASH
    Ciro Celsa, Grazia Pennisi, Federica Spatola, Aurora Giannetti, Salvatore Petta · 2020 · Springer eBooks
41. The Diagnosis of Nonalcoholic Fatty Liver Disease
    Moon Young Kim · 2014 · Korean Journal of Medicine
42. La NASH augmente-t-elle le risque cardiovasculaire ?
    Fabrice Bonnet · 2017 · Médecine des Maladies Métaboliques
43. Nonalcoholic Fatty Liver Disease
    Marco Antonio López Hernández · 2019 · IntechOpen eBooks
44. FIB-4 index associated with mortality risk of patients with systemic lupus erythematosus: a large retrospective cohort study
    Ziyi Jin, Xuebing Feng, Dandan Wang, Wenyou Pan, Lin Liu, Min Wu, Huaixia Hu, Xiang Ding, Wei Hua, Yaohong Zou et al. · 2020 · Archives of Medical Science
45. Does Nonalcoholic Fatty Liver Disease Increase the Risk for Extrahepatic Malignancies?
    Somaya A. M. Albhaisi, Arun Jayant Sanyal · 2021 · Clinical Liver Disease
46. Journal of Liver
    2019 · Journal of Liver
47. The Relation Between Non-alcoholic Fatty Liver Disease and the Risk of Coronary Heart Disease
    Seyed Moayed Alavian, Hosein Zadi · 2022 · Multidisciplinary Cardiovascular Annals
48. The hidden epidemic: Uncovering incidental fatty liver disease and its metabolic comorbidities by datamining in a hospital data lake – A real-world cohort study
    Iiro P Karhiaho, Samu H. Kurki, Helka Parviainen, Liisa Kullamaa, Martti A. Färkkilä, Niina Matikainen, Jaakko Tuomilehto · 2024 · Diabetes Research and Clinical Practice
49. Prognostic Value of the Pretransplant Fibrosis-4 Index on Non-Relapse and Overall Mortality following Unrelated Single-Unit Cord Blood Transplantation in Adults
    Takaaki Konuma, Maki Monna‐Oiwa, Seiko Kato, Masamichi Isobe, Satoshi Takahashi, Yasuhito Nannya · 2024 · Acta Haematologica
50. Evaluation of the Aspartate Aminotransferase to Platelet Ratio Index for Predicting In-Hospital Mortality in Cardiogenic Shock Patients Admitted to the Intensive Care Unit
    Min Hye Yang, Dandan Liu, Yu Liu · 2025 · Reviews in Cardiovascular Medicine
51. Multidisciplinary clinical practice guideline on the management of metabolic hepatic steatosis
    Manuel Romero‐Gómez, Javier Escalada, Mar Noguerol, Antonio Pérez, Juana Carretero, Javier Crespo, Juan José Mascort, Ignacio Aguilar, Francisco José Tinahones, Pedro Cañones et al. · 2025 · Gastroenterología y Hepatología (English Edition)
52. Metabolic factors moderate the association between hepatic fibrosis and atherosclerotic cardiovascular risk in type 2 diabetes
    Lusi Lu, Chenlu Gao, Nan Wu, Sunyue He, Yiming Liu, Nan Zhang, Jiaqiang Zhou · 2025 · BMJ Open Diabetes Research & Care
53. Effects of curcumin/turmeric supplementation on liver enzymes in subjects with prediabetes and diabetes: a systematic review and dose-response meta-analysis
    Hossein Bahari, Hossein Rafiei, Zahra Asadi, Haniyeh Golafrouz · 2026 · Journal of Diabetes & Metabolic Disorders
54. The association between dietary inflammatory index and non-alcoholic fatty liver disease: A systematic review and meta-analysis
    Jingjing Lin, Mengna Huang, Lina Shen · 2026 · PLoS ONE
55. Nonalcoholic Fatty Liver Disease: Prognosis and Progression of Disease
    Zachary H. Henry, Stephen Hugh Caldwell, Curtis Kent Argo · 2016 · Current Hepatology Reports
56. REVIEWS IN BASIC AND CLINICAL GASTROENTEROLOGY AND HEPATOLOGY
    Marc‐Emmanuel Dumas, James K. Kinross, Jeremy Kirk Nicholson · 2014
57. Hepatocellular Carcinoma: Western Experience
    Thaddeus J. Maguire, Aditya Varnam Shreenivas, William S. Rilling · 2020 · Springer eBooks
58. Prevalence and Predictors of Nonalcoholic Steatohepatitis Using Multiple Non-Invasive Methods: Data from NHANES III.
    Magda A. Shaheen, Katrina M. Schrode, Dulcie Kermah, Deyu Pan, Vishwajeet Puri, Ali Zarrinpar, David Elisha, Sonia Michael Najjar, Theodore C. Friedman · 2020 · PubMed
59. Nichtalkoholische Fettlebererkrankungen
    Elke Roeb, Ali E. Canbay · 2016 · Die Gastroenterologie
60. Research status and progress of metabolic associated fatty liver disease
    Zhao-Chun Chi · 2022 · World Chinese Journal of Digestology
61. Association of nonalcoholic fatty liver disease with thyroid functions.
    Mumtaz Ali Memon, Ramesh Kumar Suthar, Kavita Bai · 2022 · The Professional Medical Journal
62. Clinical value of thyroid related hormones combined with neutrophil to lymphocyte ratio in patients with nonalcoholic fatty liver disease
    Ping Li, Liang Liu, Bin Niu, Yuqiang Mi, Yonggang Liu, Jing Feng, Peng Zhang, Xue Wu, Weike Chu · 2022 · Medicine
63. Assessing the value of liver fibrosis scores in hypertension: findings from a cross-sectional study
    Shengjun Xiong, Wenhang Li, Shizhang Yin, Wanshu Deng, Yuanhui Zhao, Pengbo Wang, Xiaofan Guo, Yingxian Sun, Hongmei Yang · 2024 · Cardiology Plus
64. Optimizing patients with non-alcoholic fatty liver disease pre-transplant
    Amine Benmassaoud, Marc Deschênes, Tianyan Chen, Peter Ghali, Giada Sebastiani · 2020 · Canadian Liver Journal
65. Analysis of Metabolic Biomarkers in Non-Alcoholic Fatty Liver Disease (NAFLD); A Comprehensive Review
    Shagufta Akhtar, Azhar Ullah Khan · 2020 · Advanced Journal of Graduate Research
66. Non-Alcoholic Fatty Liver Disease (NAFLD) in overweight and obese children and adolescents
    Ralf Schiel, Mario Heinrichs, Günter Stein, Rolf Bambauer, Steveling Antje · 2020 · Archives of Clinical Gastroenterology
67. Non-alcoholic fatty liver disease (NAFLD) in overweight and obese children and adolescents
    Ralf Schiel, Mario Heinrichs, Günter Stein, Rolf Bambauer, Antje Steveling · 2020 · Journal of Clinical Investigation and Studies
68. Serum leptin in non-alcoholic fatty liver disease: Ambiguous clinical implications concerning cardiovascular disease
    Dimitrios Patoulias, Konstantinos P. Imprialos, Konstantinos Stavropoulos, Michael N. Doumas · 2019 · Clinical and Molecular Hepatology
69. FIB-4 First in Diagnostic Algorithm of MAFLD at the Era of “Global Metabodemic “
    Yoshio Sumida, Masashi Yoneda, Katsutoshi Tokushige, Miwa Kawanaka, Hideki Fujii, Masato Yoneda, Kento Imajo, Hirokazu Takahashi, Yuichiro Eguchi, Masafumi Ono et al. · 2020 · Preprints.org
70. Association between clinical scores of liver fibrosis and adverse non-hepatic outcomes: The key in the holistic vision of the patient
    Antonio De Vincentis, Raffaele Antonelli Incalzi, Antonio Picardi, Umberto Vespasiani Gentilucci · 2021 · Journal of Diabetes and its Complications
71. The association between Nonalcoholic Fatty Liver Disease and Cardiovascular Disease
    Narendra Singh Choudhary, Neeraj Saraf, Mohammad Shafi Kuchay, Ravi Ratan Kasliwal · 2021 · Journal of Clinical and Preventive Cardiology
72. The Worldwide Burden of NAFLD: A Systematic Review and Meta-Analysis of Prevalence and Incidence
    Kiarash Riazi, Hassan Azhari, Jacob H. Charette, Fox E. Underwood, James A. King, Elnaz Ehteshami Afshar, Mark G. Swain, Stephen E. Congly, Gilaad G. Kaplan, Abdel Aziz Shaheen · 2022 · SSRN Electronic Journal
73. Corrigendum. Guía de práctica clínica multidisciplinar de manejo de la esteatosis hepática metabólica
    Manuel Romero-Gómez, Javier Escalada, Mar Noguerol, Antonio Pérez, Juana Carretero, Javier Crespo, Juan J Mascort, Ignacio Aguilar, Francisco Tinahones, Pedro Cañones et al. · 2026 · Gastroenterología y Hepatología
74. Future watch: Evolving trends in the management of nonalcoholic steatohepatitis
    Arun Jayant Sanyal · 2015 · Clinical Liver Disease
75. Glucagon-like peptide-1 in nonalcoholic steatohepatitis
    Matthew James Armstrong · 2014 · University of Birmingham Institutional Research Archive (University of Birmingham)
76. Commentary: prognostication of chronic hepatitis B – are Fibrotest and Fibroscan the final answers? Authors' reply
    Victor de Lédinghen, J. Vergniol · 2013 · Alimentary Pharmacology & Therapeutics
77. Noninvasive markers: a double-edged sword that stratifies nonalcoholic steatohepatitis
    Goh Eun Chung, Donghee Kim · 2013 · Clinical and Molecular Hepatology
78. Statins for the Treatment of Non Alcoholic Fatty Liver Disease in Patients with Metabolic Syndrome
    Vasilios Gabriel Athyros · 2016 · Journal of Diabetes Metabolic Disorders & Control
79. Diagnostic Considerations and Clinical End Points for Nonalcoholic Steatohepatitis
    Arun Jayant Sanyal · 2015 · Springer eBooks
80. How to best diagnose NAFLD/NASH?
    Vlad Ratziu · 2016
81. La Non Alcoholic Fatty Liver Disease (NAFLD) et la Non Alcoholic Steato-Hepatitis (NASH) des pathologies de système : revue pour le réanimateur
    M. Hachemi, S. Benmakhlouf, P. Prost, N Santolaria, X. Tchenio, N. Sedillot, Fabien Zoulim · 2016 · Médecine Intensive Réanimation
82. The Association of Leptin with Severity of Non-Alcoholic Fatty Liver Disease: A Population-Based Study
    Hyun‐Seok Kim, Laura Rotundo, Mirela Feurdean · 2017 · Gastroenterology
83. Research on the intervention effect of after-dinner quick walking on community fatty liver
    Zhixin Zhang, Guo Fenglan · 2017 · Biomedical Research-tokyo
84. Effects of Smoking and Body Mass Index on Serum Liver Enzyme Levels in Chronic Kidney Disease Patients on Hemodialysis
    Fawzi I. Irshaid, Sabah Mohammad K, Abdulrahman Mohummad A, Ahmed Saad Abood · 2018 · Journal of Medical Sciences(Faisalabad)
85. Testing the ability of the nonalcoholic fatty liver disease fibrosis score to predict 1-year all-cause hospital admission
    Trace E. Heavener, Ahmed Memon, Shamyal H. Khan, Sam Davis, Lauren N. Sager, Sharon DeMorrow, Mark Jeffries · 2019 · Baylor University Medical Center Proceedings
86. Features of the non-alcoholic steatohepatitis and chronic kidney disease courses, pathogenetic correction efficiency
    Оксана Святославівна Хухліна, А. А. Антонів, O. Ie. Mandryk, O. B. Kuzminska, Інна Володимирівна Дудка, Т. В. Дудка · 2018 · Bukovinian Medical Herald
87. THE EFFECT OF HAART ON LIVER DISEASE PROGRESSION IN HIV INFECTION
    Jennifer C. Price · 2015
88. iLFT: A big assist in the recognition of liver disease in general practice
    Amanda C. Cheung, Paul Yien Kwo · 2019 · Journal of Hepatology
89. Road to identifying endpoint biomarkers in the treatment of nonalcoholic steatohepatitis: are we there yet?
    Donghee Kim, Luis Miguel Vazquez‐Montesino, Aijaz Ahmed · 2020 · HepatoBiliary Surgery and Nutrition
90. Obesity-induced hepatic changes during pregnancy
    Luís F. Grilo · 2019 · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
91. Hepatic steatosis, steatohepatitis, and chemotherapy-related liver injury
    Srinevas K. Reddy, David A. Geller · 2017 · Elsevier eBooks
92. Goals of therapy and concurrent lifestyle interventions to compliment endoscopic bariatric and metabolic interventions
    Mark A. Gromski, Shelby A. Sullivan · 2020 · Techniques and Innovations in Gastrointestinal Endoscopy
93. EVALUATION OF KEY PERFLUOROALKYL SUBSTANCES TO INDUCE LIVER STEATOSIS IN MOUSE AND HUMAN MODELS
    Emily Marques · 2020
94. Real Time Elastography is an Easy Tool for Diagnosis of Liver Fibrosis in Non-Alcoholic Fatty Liver Disease
    Badawy Abdulkhalik Abdulaziz, Mohamed El–Tantawy Ibrahim, Medhat A. Khalil, Walid A. Abdel Halim · 2020 · Open Journal of Medical Imaging
95. Non-invasive Diagnostic Approach to NASH: Biological Markers
    Salvatore Petta, Aurora Giannetti · 2020 · Springer eBooks
96. Diagnostic Assessment of Nonalcoholic Fatty Liver Disease
    Young‐Joo Jin · 2020 · Korean Journal of Medicine
97. Non-alcoholic fatty liver disease as metabolic consequence of obstructive sleep apnea
    Ana Ninić, Marija D. Zdravkovic, Vojislav Radosavljević, Vera Gardijan, Lidija Memon, Jelena Vekić, Vesna Spasojević‐Kalimanovska · 2020 · Arhiv za farmaciju
98. Letter: significant burden of nonalcoholic fatty liver disease with advanced fibrosis in the USA: a cross‐sectional analysis of 2011‐2014 National Health and Nutrition Examination Survey – author's reply
    Robert J. Wong · 2018 · Alimentary Pharmacology & Therapeutics
99. 비알코올 지방간 질환의 진단
    Moon Young Kim · 2014
100. Сучасні можливості діагностики віcцерального ожиріння та його практичне значення
     G. D. Fadieienko, Y. V. Nikiforova, Олена Степанова · 2020